1. Home
  2. IPI vs CCCC Comparison

IPI vs CCCC Comparison

Compare IPI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPI
  • CCCC
  • Stock Information
  • Founded
  • IPI 2000
  • CCCC 2015
  • Country
  • IPI United States
  • CCCC United States
  • Employees
  • IPI N/A
  • CCCC N/A
  • Industry
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • IPI Industrials
  • CCCC Health Care
  • Exchange
  • IPI Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • IPI 475.8M
  • CCCC 104.4M
  • IPO Year
  • IPI 2008
  • CCCC 2020
  • Fundamental
  • Price
  • IPI $35.05
  • CCCC $2.26
  • Analyst Decision
  • IPI Strong Sell
  • CCCC Buy
  • Analyst Count
  • IPI 1
  • CCCC 3
  • Target Price
  • IPI $19.00
  • CCCC $12.00
  • AVG Volume (30 Days)
  • IPI 146.8K
  • CCCC 1.6M
  • Earning Date
  • IPI 08-04-2025
  • CCCC 07-31-2025
  • Dividend Yield
  • IPI N/A
  • CCCC N/A
  • EPS Growth
  • IPI N/A
  • CCCC N/A
  • EPS
  • IPI N/A
  • CCCC N/A
  • Revenue
  • IPI $217,865,000.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • IPI $11.06
  • CCCC N/A
  • Revenue Next Year
  • IPI N/A
  • CCCC N/A
  • P/E Ratio
  • IPI N/A
  • CCCC N/A
  • Revenue Growth
  • IPI N/A
  • CCCC 98.56
  • 52 Week Low
  • IPI $20.75
  • CCCC $1.09
  • 52 Week High
  • IPI $39.01
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • IPI 42.90
  • CCCC 63.62
  • Support Level
  • IPI $35.84
  • CCCC $1.36
  • Resistance Level
  • IPI $37.84
  • CCCC $2.17
  • Average True Range (ATR)
  • IPI 1.20
  • CCCC 0.15
  • MACD
  • IPI -0.12
  • CCCC 0.05
  • Stochastic Oscillator
  • IPI 23.35
  • CCCC 67.11

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: